Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 54 (HNRNPA1P54)

Target
HNRNPA1P54
Molecular classification
Other (Pseudogene)
01

Overview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 54 (HNRNPA1P54) is a **pseudogene**—a non-functional genomic DNA sequence similar to the functional HNRNPA1 gene, which encodes an RNA-binding protein involved in pre-mRNA processing and splicing[1][4][7]. Pseudogenes generally do not produce a functional protein due to disabling mutations or lack of transcription. HNRNPA1P54 itself is not known to have any biological function, disease association, or role as a therapeutic target; there are no reported interacting drugs, mechanisms of action, or biomarker utility[1][4][7]. Pseudogenes can occasionally have regulatory roles at the RNA level (e.g., as competing endogenous RNAs in some forms of cancer), but there is no documented evidence that HNRNPA1P54 has such a function[7]. Importantly, confusion often arises because its parent gene, HNRNPA1, is functionally significant in RNA metabolism, cell stress response, some cancers, and neurodegenerative diseases; this is not the case for the pseudogene HNRNPA1P54[2][3][6][8]. **Summary Interpretation:** - **HNRNPA1P54** is not a protein-coding gene, not a proven therapeutic target, and not associated with actionable functions or diseases. - The entry is arguably "incorrect" as a therapeutic target or receptor because it is a pseudogene, and any functional attributes pertain to HNRNPA1, not HNRNPA1P54[1][4][7].

Other names
HNRNPA1P54heterogeneous nuclear ribonucleoprotein A1 pseudogene 54

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 54 (HNRNPA1P54).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 54 (HNRNPA1P54).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call